HeartCycle

HeartCycle consortium, comprising 18 research, academic, industrial and medical organizations from 9 different European countries and China, will work to improve the quality of life for coronary heart disease and heart failure patients by monitoring their condition and involving them in the daily management of their disease. The consortium will also develop mechanisms to automatically report relevant monitoring data back to clinicians so that they can prescribe personalized therapies and lifestyle recommendations.

Compliance to prescribed therapies is a common problem associated with long-term treatment, and will become even more problematic as the European population ages and chronic disease becomes more prevalent. There is strong evidence that increasing the level of patient compliance may have a far greater impact on the health of the population than improvements in specific medical treatments. The HeartCycle project intends to tackle this in two ways.

Firstly by creating a 'patient loop' that gives patients continuous feedback on their state of health, their progress towards achieving health status milestones, plus motivational tips and suggestions for a healthy lifestyle and diet. In the course of the project it will be investigated whether such measures will improve the adherence to prescribed therapies. Monitoring each patient's condition will be achieved using a combination of unobtrusive bio-sensors built into the patient's clothing or bed sheets and home appliances such as weighing scales and blood pressure monitors. Sensing of an individual patient's physical exertion, body orientation and ambient environment will provide additional information so that the system can put the monitoring data into context.

Secondly by enabling a 'professional loop' in which relevant data on a patient’s state of health and therapy adherence is automatically communicated to a hospital information system. This professional loop will allow doctors to monitor each patient's condition and therapy response in order to create optimized individual care plans, as well as allowing them to identify deterioration or sudden cardiac events that require immediate remedial action.

For further information, please visit:
http://www.heartcycle.eu

Project co-ordinator:
Philips Research

Partners:

  • Aristotle University of Thessaloniki (Greece);
  • Clothing Plus Oy (Finland);
  • CSEM Centre Suisse D'electronique Et De Microtechnique Sa (Switzerland);
  • Empirica Gesellschaft für Kommunikations und Technologieforschung mbH (Germany);
  • Faculdade Ciencias e Tecnologia da Universidade de Coimbra (Portugal);
  • Fundación Vodafone España (Spain);
  • Hospital Universitario Clínico San Carlos (Spain);
  • Instituto de Aplicaciones de las Tecnologías de la Información y de las Comunicaciones Avanzadas (Spain);
  • Medtronic Ibérica SA (Spain);
  • Philips Electronics Nederland B.V. (The Netherlands);
  • Philips Research (Germany);
  • Politecnico Di Milano - Dipartimento di Bioingegneria (Italy);
  • Rheinisch Westfälische Technische Hochschule (Germany);
  • T-Systems ITC Iberia SA (Spain);
  • Universidad Politécnica de Madrid (Spain);
  • Chinese University of Hong Kong (China);
  • University of Hull (United Kingdom);
  • Valtion Teknillinen Tutkimuskeskus (Finland).

Timetable: from 03/2008 – to 02/2012

Total cost: € 21.985.444

EC funding: € 14.100.000

Programme Acronym: FP7-ICT

Subprogramme Area: Personal health systems for monitoring and point-of-care diagnostics

Contract type: Collaborative project (generic)


Related news articles:

Most Popular Now

Leading Health Systems Sign On to Delive…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the expanding adoption of its Population Health Management solutions with health systems across the globe, including...

Pflegetiger Adds Digital Health Ventures…

Since summer 2016, Pflegetiger has been developing its innovative concept of neighborhood care, a concept designed to make in-home care attractive for care professionals again. The company's revolutionary approach -...

Can Virtual Reality be Used to Manage Pa…

Virtual reality has emerged into popular culture with an ever-widening array of applications including clinical use in a pediatric healthcare center. Children undergo necessary yet painful and distressing medical procedures...

Free iPhone App could Guide MS Research…

For some diseases, a simple blood test is all that's needed to estimate severity or confirm a diagnosis. Not so for multiple sclerosis. No single lab test can tell doctors...

Using Social Media Big Data to Combat Pr…

Researchers at Dartmouth, Stanford University, and IBM Research, conducted a critical review of existing literature to determine whether social media big data can be used to understand communication and behavioral...

B.Braun Accelerator Call for Innovative …

B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. The company employs more than 60,000 employees in 64 countries and is looking for European...

'NHS Cyber Security Batsignal' Peer-to-P…

The two chairs of the largest independent communities of NHS digital leaders will launch the 'NHS Cyber Security Batsignal', a new peer-to-peer cyber security warning alerting system, at the first...

Giving Rookie Dads the Online Info they …

Expectant and new parents often turn to the internet for parenting prep, but it turns out that dads often don't seem to find the information they say they need about...

Artificial Intelligence to Evaluate Brai…

Researchers at the University of Helsinki and the Helsinki University Hospital (HUH), Finland, have developed software based on machine learning, which can independently interpret EEG signals from a premature infant...

FDA Approves Pill with Sensor that Digit…

The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor...

Philips Partners with Dutch Health Insur…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is collaborating with Dutch health insurer ONVZ to provide an industry first, strategic cooperation...